-
EP1890677
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1890677
| EP1890677 - PHARMACEUTICAL COMPOSITIONS AND USE THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.01.2014 Database last updated on 12.07.2024 | Most recent event Tooltip | 03.01.2014 | Application deemed to be withdrawn | published on 05.02.2014 [2014/06] | Applicant(s) | For all designated states MYRIAD GENETICS, INC. 320 Wakara Way Salt Lake City Utah 84108 / US | [2008/09] | Inventor(s) | 01 /
ZENTNER, Gaylen, M. 6312 S. Colleton Circle Salt Lake City, Utah 84121 / US | 02 /
SHIH, Chung 2798 Amberwick Lane Sandy, Utah 84093 / US | 03 /
MCREA, James, C. 320 Wakara Way Salt Lake City, Utah 84108 / US | [2008/09] | Representative(s) | Adam, Holger Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | [N/P] |
| Former [2008/09] | Adam, Holger Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15 80539 München / DE | Application number, filing date | 06773394.9 | 16.06.2006 | [2008/09] | WO2006US23566 | Priority number, date | US20050691362P | 16.06.2005 Original published format: US 691362 P | [2008/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006138608 | Date: | 28.12.2006 | Language: | EN | [2006/52] | Type: | A2 Application without search report | No.: | EP1890677 | Date: | 27.02.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.12.2006 takes the place of the publication of the European patent application. | [2008/09] | Search report(s) | International search report - published on: | US | 26.04.2007 | (Supplementary) European search report - dispatched on: | EP | 07.01.2013 | Classification | IPC: | A61K9/00, A61K31/00, A61K36/00, A61K35/00, A61K38/00 | [2008/09] | CPC: |
A61K31/517 (EP,KR,US);
A61K9/0019 (EP,US);
A61K9/08 (KR);
A61P17/00 (EP);
A61P17/06 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P9/10 (EP);
A61K47/02 (EP,US);
A61K47/10 (EP,US);
A61K47/14 (EP,US);
A61K47/26 (EP,US);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/09] | Extension states | RS | 23.10.2007 | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND IHRE VERWENDUNG | [2008/09] | English: | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | [2008/09] | French: | COMPOSITIONS PHARMACEUTIQUES ET LEUR UTILISATION | [2008/09] | Entry into regional phase | 23.10.2007 | National basic fee paid | 23.10.2007 | Search fee paid | 23.10.2007 | Designation fee(s) paid | 23.10.2007 | Examination fee paid | Examination procedure | 23.10.2007 | Examination requested [2008/09] | 06.08.2013 | Application deemed to be withdrawn, date of legal effect [2014/06] | 12.09.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/06] | Fees paid | Renewal fee | 18.03.2008 | Renewal fee patent year 03 | 05.06.2009 | Renewal fee patent year 04 | 11.06.2010 | Renewal fee patent year 05 | 13.06.2011 | Renewal fee patent year 06 | 14.06.2012 | Renewal fee patent year 07 | 31.03.2013 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2005003100 (MYRIAD GENETICS INC [US], et al) [X] 1,2,4,5,7-9,11,15,16,18,21,22,25,26,28,30-35,38-45 * paragraph [0344] * * claims 93, 94, 97, 99, 103-114 * * example 148 * [I] 3,6,10,12-14,17,19,20,23,24,27,29,36,37; | [A]WO0056338 (PARKER HUGHES INST [US], et al) [A] 1-45 * page 1, lines 7-9 * * examples 1-13 * * claims 1-20 * | International search | [X]US6251912 (WISSNER ALLAN [US], et al); | [X]US7087613 (NORRIS TIMOTHY [US], et al); | [A] - HWANG S.R. ET AL., "Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration", INT. J. PHARM., (20040519), vol. 276, no. 1-2, pages 175 - 183, XP003010760 DOI: http://dx.doi.org/10.1016/j.ijpharm.2004.02.025 |